Tumor | Treatment (mg/kg) on day 0–day 2 |
HCC827 | Erlotinib (50) |
Erlotinib (150) | |
H1975 | Erlotinib (50) |
Erlotinib (150) | |
CL-387,785 (50) | |
WZ4002 (25) | |
WZ4002 (50) | |
H1650 | Erlotinib (50) |
Erlotinib (150) | |
ABT-263 (6.25) | |
Erlotinib (50) + ABT-263 (6.25) |
Treatment was started 3 h after baseline 18F-FLT scan on day 0 and was stopped 3 h before posttreatment 18F-FLT scan on day 2.